Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI), covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage [Phase 2]